Molecular Liabilities And Stockholders Equity from 2010 to 2024
| MTEM Stock | USD 0.38 0.01 2.56% |
Liabilities And Stockholders Equity | First Reported 2004-09-30 | Previous Quarter 27.1 M | Current Value 26.7 M | Quarterly Volatility 55.3 M |
Check Molecular Templates financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Molecular Templates' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7 M, Interest Expense of 2.8 M or Other Operating Expenses of 49.9 M, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0067 or PTB Ratio of 4.19. Molecular financial statements analysis is a perfect complement when working with Molecular Templates Valuation or Volatility modules.
Molecular | Liabilities And Stockholders Equity |
Latest Molecular Templates' Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of Molecular Templates over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Molecular Templates' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Molecular Templates' overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
Molecular Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 84,845,590 | |
| Geometric Mean | 62,482,756 | |
| Coefficient Of Variation | 67.70 | |
| Mean Deviation | 46,588,304 | |
| Median | 89,521,000 | |
| Standard Deviation | 57,443,709 | |
| Sample Variance | 3299.8T | |
| Range | 185.6M | |
| R-Value | 0.34 | |
| Mean Square Error | 3137.7T | |
| R-Squared | 0.12 | |
| Significance | 0.21 | |
| Slope | 4,394,257 | |
| Total Sum of Squares | 46196.9T |
Molecular Liabilities And Stockholders Equity History
About Molecular Templates Financial Statements
Molecular Templates investors utilize fundamental indicators, such as Liabilities And Stockholders Equity, to predict how Molecular Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 35.4 M | 33.6 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Molecular Templates Correlation against competitors. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.